- cafead   Dec 19, 2023 at 11:22: PM
via On Tuesday, Roche revealed that the FDA has accepted its supplemental biologics license application (sBLA) on a priority review basis for Xolair to reduce accidental allergic food reactions, including anaphylaxis, in adults and children ages 1 year and older.
article source
article source